Intercept Pharmaceuticals, Inc.
TGR5 MODULATORS AND METHODS OF USE THEREOF

Last updated:

Abstract:

The invention relates to compounds of Formula A: ##STR00001## or a salt, solvate, hydrate, or prodrug thereof. The compounds of Formula A are TGR5 modulators useful for the treatment of various diseases, including metabolic disease, inflammatory disease, liver disease, autoimmune disease, cardiac disease, kidney disease, cancer, and gastrointestinal disease.

Status:
Application
Type:

Utility

Filling date:

9 Nov 2020

Issue date:

2 Sep 2021